UK markets closed

PCI Biotech Holding ASA (PCIB.OL)

Oslo - Oslo Delayed price. Currency in NOK
Add to watchlist
1.5400-0.0460 (-2.90%)
At close: 02:51PM CEST
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-20,315
-20,315
-55,095
-88,391
-72,239
Depreciation & amortisation
371
371
6,406
2,541
2,208
Stock-based compensation
1,955
1,955
-1,294
12,939
6,339
Change in working capital
2,972
2,972
-8,937
2,037
-5,248
Other working capital
-14,970
-14,970
-59,042
-68,307
-77,391
Other non-cash items
47
47
78
38
75
Net cash provided by operating activities
-14,970
-14,970
-59,042
-68,307
-77,391
Cash flows from investing activities
Acquisitions, net
-
-
0
0
0
Other investing activities
-
-
-
-341
-3,919
Net cash used for investing activities
0
0
0
-341
-3,919
Net change in cash
-15,412
-15,412
-59,720
-69,321
-81,662
Cash at beginning of period
56,596
56,596
116,118
187,967
261,103
Cash at end of period
41,184
41,184
56,596
116,118
187,967
Free cash flow
Operating cash flow
-14,970
-14,970
-59,042
-68,307
-77,391
Free cash flow
-14,970
-14,970
-59,042
-68,307
-77,391